Nuveen’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07B Buy
2,696,634
+75,211
+3% +$32.9M 0.26% 76
2026
Q1
$1.21B Sell
2,621,423
-109,059
-4% -$55.2M 0.33% 55
2025
Q4
$1.55B Sell
2,730,482
-210,404
-7% -$112M 0.4% 40
2025
Q3
$1.32B Sell
2,940,886
-287,576
-9% -$138M 0.35% 49
2025
Q2
$1.75B Sell
3,228,462
-236,110
-7% -$123M 0.48% 27
2025
Q1
$1.72B Buy
3,464,572
+30,011
+0.9% +$16.6M 0.52% 31
2024
Q4
$1.79B Sell
3,434,561
-75,704
-2% -$39.4M 0.51% 27
2024
Q3
$1.72B Buy
3,510,265
+37,759
+1% +$17.6M 0.48% 30
2024
Q2
$1.54B Sell
3,472,506
-174,865
-5% -$69.6M 0.45% 33
2024
Q1
$1.46B Buy
3,647,371
+242,251
+7% +$91.5M 0.43% 40
2023
Q4
$1.15B Buy
3,405,120
+101,680
+3% +$30.3M 0.37% 52
2023
Q3
$966M Buy
3,303,440
+8,838
+0.3% +$2.76M 0.34% 63
2023
Q2
$1.13B Sell
3,294,602
-335,520
-9% -$102M 0.39% 52
2023
Q1
$927M Buy
3,630,122
+310,319
+9% +$76.4M 0.34% 66
2022
Q4
$881M Sell
3,319,803
-40,921
-1% -$9.98M 0.34% 69
2022
Q3
$630M Sell
3,360,724
-109,446
-3% -$23.5M 0.26% 84
2022
Q2
$696M Buy
3,470,170
+338,498
+11% +$79.4M 0.27% 82
2022
Q1
$887M Buy
3,131,672
+38,150
+1% +$11.1M 0.29% 69
2021
Q4
$1.11B Sell
3,093,522
-94,425
-3% -$32.5M 0.33% 58
2021
Q3
$1.06B Sell
3,187,947
-19,014
-0.6% -$6.38M 0.33% 58
2021
Q2
$983M Buy
3,206,961
+742,380
+30% +$208M 0.29% 71
2021
Q1
$607M Buy
2,464,581
+26,184
+1% +$6.59M 0.19% 107
2020
Q4
$665M Sell
2,438,397
-604,554
-20% -$150M 0.23% 86
2020
Q3
$720M Buy
3,042,951
+1,000,602
+49% +$225M 0.28% 79
2020
Q2
$388M Sell
2,042,349
-821,499
-29% -$147M 0.16% 120
2020
Q1
$473M Sell
2,863,848
-1,590,840
-36% -$291M 0.23% 101
2019
Q4
$878M Sell
4,454,688
-189,705
-4% -$35.5M 0.33% 59
2019
Q3
$836M Sell
4,644,393
-898,980
-16% -$155M 0.34% 57
2019
Q2
$969M Buy
5,543,373
+5,526,561
+32,873% +$947M 0.38% 47
2019
Q1
$3.2M Sell
16,812
-102
-0.6% -$18.1K 0.02% 575
2018
Q4
$2.7M Buy
16,914
+354
+2% +$60K 0.02% 578
2018
Q3
$3.17M Sell
16,560
-303
-2% -$53.8K 0.02% 586
2018
Q2
$2.69M Buy
16,863
+7,872
+88% +$1.2M 0.02% 582
2018
Q1
$1.24M Buy
8,991
+294
+3% +$41K 0.01% 711
2017
Q4
$1.06M Buy
8,697
+1,785
+26% +$223K 0.01% 734
2017
Q3
$803K Buy
6,912
+558
+9% +$60.8K 0.01% 816
2017
Q2
$660K Sell
6,354
-11,061
-64% -$1.06M ﹤0.01% 861
2017
Q1
$1.48M Sell
17,415
-78,435
-82% -$6.2M 0.01% 803
2016
Q4
$6.75M Buy
+95,850
New +$7.05M 0.03% 556
2016
Q2
Sell
-21,627
Closed -$1.44K 1362
2016
Q1
$1.44K Buy
21,627
+99
+0.5% +$6.13K 0.01% 878
2015
Q4
$1.31K Sell
21,528
-1,485
-6% -$83.4K 0.01% 943
2015
Q3
$1.18K Buy
23,013
+1,107
+5% +$62.7K 0.01% 998
2015
Q2
$1.18K Hold
21,906
0.01% 1081
2015
Q1
$1.23M Sell
21,906
-4,671
-18% -$264K 0.01% 1077
2014
Q4
$1.56M Sell
26,577
-6,912
-21% -$385K 0.01% 973
2014
Q3
$1.72M Buy
33,489
+10,215
+44% +$507K 0.01% 877
2014
Q2
$1.06M Sell
23,274
-1,782
-7% -$78.6K 0.01% 1136
2014
Q1
$1.22M Sell
25,056
-1,206
-5% -$56.8K 0.01% 1033
2013
Q4
$1.12M Buy
+26,262
New +$1.1M 0.01% 1047
2013
Q3
Sell
-28,935
Closed -$1.63M 1521
2013
Q2
$1.63M Buy
+28,935
New +$1.59M 0.01% 830

Other funds holding ISRG

Nuveen's ISRG Position: Q2 2026 in Review

Nuveen increased its Intuitive Surgical (ISRG) stake by 2.9% in Q2 2026, buying an estimated $32.9M and bringing the position to 2,696,634 shares worth $1.07B. The position accounts for 0.26% of the portfolio, ranked #76.

Nuveen first reported a position in ISRG in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.79B in Q4 2024. 2,231 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Nuveen held 2,696,634 shares of Intuitive Surgical worth $1.07B as of Q2 2026.
  • Nuveen bought 75,211 Intuitive Surgical shares in Q2 2026, an estimated $32.9M.
  • Intuitive Surgical made up 0.26% of Nuveen's portfolio in Q2 2026, its #76 holding.
  • Nuveen first reported a position in Intuitive Surgical in Q2 2013 and has held it in 50 quarters since.
  • Nuveen's Intuitive Surgical position peaked at $1.79B in Q4 2024.
  • 2,231 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.